CytoSorbents Announces Third Quarter 2026 Financial Results Date
CytoSorbents Corporation (NASDAQ: CTSO) has scheduled the release of its third quarter 2026 financial results and recent business highlights for Thursday, November 12, 2026. The announcement will occur after the market close, followed by a live presentation webcast and Q&A session at 4:30 PM ET. The company, which specializes in blood purification technologies for intensive care and cardiac surgery, is currently focused on its lead product CytoSorb® and the development of the DrugSorb®-ATR antithrombotic removal system. Investors will be looking for updates regarding regulatory progress in the U.S. and Canada, as well as commercial performance following recent FDA Breakthrough Device Designations.
